---
document_datetime: 2025-12-29 11:20:16
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/nexium-control.html
document_name: nexium-control.html
version: success
processing_time: 0.1137133
conversion_datetime: 2025-12-31 01:19:20.457856
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Nexium Control

[RSS](/en/individual-human-medicine.xml/66955)

##### Authorised

This medicine is authorised for use in the European Union

esomeprazole Medicine Human Authorised

On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [More information on Nexium Control](#related-medicines)
- [Topics](#topics)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

This is a summary of the European public assessment report (EPAR) for Nexium Control. It explains how the European Medicines Agency assessed the medicine to recommend its authorisation in the European Union (EU) and its conditions of use. It is not intended to provide practical advice on how to use Nexium Control.

For practical information about using Nexium Control, patients should read the package leaflet or contact their doctor or pharmacist.

Expand section

Collapse section

## What is Nexium Control and what is it used for?

Nexium Control is a medicine that contains the active substance esomeprazole. It is used in adults for the short-term treatment of reflux symptoms (sometimes called acid reflux), such as heartburn and acid regurgitation.

Nexium Control is similar to a 'reference medicine' already authorised in the European Union (EU) containing the same active substance, called Nexium. The reference medicine is only available with a prescription, but Nexium Control is intended for short-term use without a prescription.

## How is Nexium Control used?

Nexium Control can be obtained without a prescription. It is available as tablets (20 mg) which are gastroresistant (the contents pass through the stomach without being broken down until they reach the intestine). The recommended dose is one tablet per day for up to two weeks until the symptoms are relieved. If symptoms persist after two weeks, the patient should see a doctor. For further information, see the package leaflet.

## How does Nexium Control work?

The active substance in Nexium Control, esomeprazole, is a proton-pump inhibitor. It works by blocking 'proton pumps', proteins found in specialised cells in the stomach lining, which pump acid into the stomach. By blocking the pumps, esomeprazole reduces acid production, thereby relieving the symptoms of acid reflux.

## What benefits of Nexium Control have been shown in studies?

Nexium Control has been compared with placebo (a dummy treatment) in two main studies involving 718 adult patients with reflux symptoms including heartburn. The patients were treated for four weeks. The main measure of effectiveness in both studies was the percentage of patients whose heartburn symptoms had completely cleared up at the end of the study.

In the first study, around 34% of patients taking a 20 mg dose of Nexium Control (41 out of 121) had no more heartburn symptoms, compared with around 14% of patients taking placebo (17 out of 124). In the second study, around 42% of patients taking Nexium Control (47 out of 113) had no more heartburn symptoms, compared with around 12% of patients taking placebo (14 out of 118). In both studies, most patients whose symptoms completely cleared up had already achieved this in the first two weeks, while patients whose symptoms did not completely clear up in two weeks showed little further improvement from continued treatment.

## What are the risks associated with Nexium Control?

Headache, abdominal pain, diarrhoea and nausea are among the most common side effects with Nexium Control (which may affect up to 1 in 10 patients). For the full list of all side effects reported with Nexium Control, see the package leaflet.

Nexium Control must not be used together with another medicine called nelfinavir (used to treat HIV infection). For the full list of restrictions, see the package leaflet.

## Why is Nexium Control approved?

The Agency's Committee for Medicinal Products for Human Use (CHMP) decided that Nexium Control's benefits are greater than its risks and recommended that it be approved for use in the EU. The CHMP concluded that the medicine's effects were already well established, as esomeprazole-containing medicines have been authorised in EU countries since 2000, and that its short-term benefits had been demonstrated in studies where most patients' symptoms cleared up in two weeks. The Committee concluded that patients could safely treat themselves with the medicine for up to two weeks.

## What measures are being taken to ensure the safe and effective use of Nexium Control?

A risk management plan has been developed to ensure that Nexium Control is used as safely as possible. Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Nexium Control, including the appropriate precautions to be followed by healthcare professionals and patients.

## Other information about Nexium Control

The European Commission granted a marketing authorisation valid throughout the European Union for Nexium Control on 26 August 2013.

For more information about treatment with Nexium Control, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.

Nexium Control : EPAR - Summary for the public

Adopted

Reference Number: EMA/410916/2013

English (EN) (74.66 KB - PDF)

**First published:** 19/09/2013

**Last updated:** 19/09/2013

[View](/en/documents/overview/nexium-control-epar-summary-public_en.pdf)

[Other languages (22)](#file-language-dropdown-163)

български (BG) (103.52 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

19/09/2013

[View](/bg/documents/overview/nexium-control-epar-summary-public_bg.pdf)

español (ES) (74.45 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

19/09/2013

[View](/es/documents/overview/nexium-control-epar-summary-public_es.pdf)

čeština (CS) (99.76 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

19/09/2013

[View](/cs/documents/overview/nexium-control-epar-summary-public_cs.pdf)

dansk (DA) (74.05 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

19/09/2013

[View](/da/documents/overview/nexium-control-epar-summary-public_da.pdf)

Deutsch (DE) (75.64 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

19/09/2013

[View](/de/documents/overview/nexium-control-epar-summary-public_de.pdf)

eesti keel (ET) (73.94 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

19/09/2013

[View](/et/documents/overview/nexium-control-epar-summary-public_et.pdf)

ελληνικά (EL) (100.62 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

19/09/2013

[View](/el/documents/overview/nexium-control-epar-summary-public_el.pdf)

français (FR) (74.78 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

19/09/2013

[View](/fr/documents/overview/nexium-control-epar-summary-public_fr.pdf)

hrvatski (HR) (92.85 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

19/09/2013

[View](/hr/documents/overview/nexium-control-epar-summary-public_hr.pdf)

italiano (IT) (96.13 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

19/09/2013

[View](/it/documents/overview/nexium-control-epar-summary-public_it.pdf)

latviešu valoda (LV) (113.11 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

19/09/2013

[View](/lv/documents/overview/nexium-control-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (98.79 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

19/09/2013

[View](/lt/documents/overview/nexium-control-epar-summary-public_lt.pdf)

magyar (HU) (93.93 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

19/09/2013

[View](/hu/documents/overview/nexium-control-epar-summary-public_hu.pdf)

Malti (MT) (100.57 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

19/09/2013

[View](/mt/documents/overview/nexium-control-epar-summary-public_mt.pdf)

Nederlands (NL) (74.51 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

19/09/2013

[View](/nl/documents/overview/nexium-control-epar-summary-public_nl.pdf)

polski (PL) (100.86 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

19/09/2013

[View](/pl/documents/overview/nexium-control-epar-summary-public_pl.pdf)

português (PT) (74.57 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

19/09/2013

[View](/pt/documents/overview/nexium-control-epar-summary-public_pt.pdf)

română (RO) (96.72 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

19/09/2013

[View](/ro/documents/overview/nexium-control-epar-summary-public_ro.pdf)

slovenčina (SK) (120.61 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

19/09/2013

[View](/sk/documents/overview/nexium-control-epar-summary-public_sk.pdf)

slovenščina (SL) (94.16 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

19/09/2013

[View](/sl/documents/overview/nexium-control-epar-summary-public_sl.pdf)

Suomi (FI) (72.58 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

19/09/2013

[View](/fi/documents/overview/nexium-control-epar-summary-public_fi.pdf)

svenska (SV) (74.02 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

19/09/2013

[View](/sv/documents/overview/nexium-control-epar-summary-public_sv.pdf)

Nexium Control : EPAR - Risk management plan

English (EN) (128.54 KB - PDF)

**First published:** 30/01/2025

[View](/en/documents/rmp/nexium-control-epar-risk-management-plan_en.pdf)

## Product information

Nexium Control : EPAR - Product Information

English (EN) (482.74 KB - PDF)

**First published:** 19/09/2013

**Last updated:** 30/01/2025

[View](/en/documents/product-information/nexium-control-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-565)

български (BG) (471.21 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

30/01/2025

[View](/bg/documents/product-information/nexium-control-epar-product-information_bg.pdf)

español (ES) (1.27 MB - PDF)

**First published:**

19/09/2013

**Last updated:**

30/01/2025

[View](/es/documents/product-information/nexium-control-epar-product-information_es.pdf)

čeština (CS) (556.14 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

30/01/2025

[View](/cs/documents/product-information/nexium-control-epar-product-information_cs.pdf)

dansk (DA) (517.39 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

30/01/2025

[View](/da/documents/product-information/nexium-control-epar-product-information_da.pdf)

Deutsch (DE) (628.66 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

30/01/2025

[View](/de/documents/product-information/nexium-control-epar-product-information_de.pdf)

eesti keel (ET) (891.84 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

30/01/2025

[View](/et/documents/product-information/nexium-control-epar-product-information_et.pdf)

ελληνικά (EL) (572.96 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

30/01/2025

[View](/el/documents/product-information/nexium-control-epar-product-information_el.pdf)

français (FR) (476.08 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

30/01/2025

[View](/fr/documents/product-information/nexium-control-epar-product-information_fr.pdf)

hrvatski (HR) (641.05 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

30/01/2025

[View](/hr/documents/product-information/nexium-control-epar-product-information_hr.pdf)

íslenska (IS) (528.01 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

30/01/2025

[View](/is/documents/product-information/nexium-control-epar-product-information_is.pdf)

italiano (IT) (665.08 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

30/01/2025

[View](/it/documents/product-information/nexium-control-epar-product-information_it.pdf)

latviešu valoda (LV) (749.68 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

30/01/2025

[View](/lv/documents/product-information/nexium-control-epar-product-information_lv.pdf)

lietuvių kalba (LT) (798.1 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

30/01/2025

[View](/lt/documents/product-information/nexium-control-epar-product-information_lt.pdf)

magyar (HU) (568.86 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

30/01/2025

[View](/hu/documents/product-information/nexium-control-epar-product-information_hu.pdf)

Malti (MT) (646.87 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

30/01/2025

[View](/mt/documents/product-information/nexium-control-epar-product-information_mt.pdf)

Nederlands (NL) (474.13 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

30/01/2025

[View](/nl/documents/product-information/nexium-control-epar-product-information_nl.pdf)

norsk (NO) (491.69 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

30/01/2025

[View](/no/documents/product-information/nexium-control-epar-product-information_no.pdf)

polski (PL) (660.74 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

30/01/2025

[View](/pl/documents/product-information/nexium-control-epar-product-information_pl.pdf)

português (PT) (454.2 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

30/01/2025

[View](/pt/documents/product-information/nexium-control-epar-product-information_pt.pdf)

română (RO) (617.04 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

30/01/2025

[View](/ro/documents/product-information/nexium-control-epar-product-information_ro.pdf)

slovenčina (SK) (564.34 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

30/01/2025

[View](/sk/documents/product-information/nexium-control-epar-product-information_sk.pdf)

slovenščina (SL) (491.97 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

30/01/2025

[View](/sl/documents/product-information/nexium-control-epar-product-information_sl.pdf)

Suomi (FI) (499.8 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

30/01/2025

[View](/fi/documents/product-information/nexium-control-epar-product-information_fi.pdf)

svenska (SV) (485.15 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

30/01/2025

[View](/sv/documents/product-information/nexium-control-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** PSUSA/00001269/202403 13/01/2025

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Nexium Control : EPAR - All Authorised presentations

English (EN) (30.66 KB - PDF)

**First published:** 19/09/2013

**Last updated:** 10/07/2020

[View](/en/documents/all-authorised-presentations/nexium-control-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-490)

български (BG) (34.29 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

10/07/2020

[View](/bg/documents/all-authorised-presentations/nexium-control-epar-all-authorised-presentations_bg.pdf)

español (ES) (30.39 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

10/07/2020

[View](/es/documents/all-authorised-presentations/nexium-control-epar-all-authorised-presentations_es.pdf)

čeština (CS) (32.02 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

10/07/2020

[View](/cs/documents/all-authorised-presentations/nexium-control-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (31.13 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

10/07/2020

[View](/da/documents/all-authorised-presentations/nexium-control-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (32.78 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

10/07/2020

[View](/de/documents/all-authorised-presentations/nexium-control-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (31.35 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

10/07/2020

[View](/et/documents/all-authorised-presentations/nexium-control-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (33.75 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

10/07/2020

[View](/el/documents/all-authorised-presentations/nexium-control-epar-all-authorised-presentations_el.pdf)

français (FR) (30.68 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

10/07/2020

[View](/fr/documents/all-authorised-presentations/nexium-control-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (38.24 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

10/07/2020

[View](/hr/documents/all-authorised-presentations/nexium-control-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (31.59 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

10/07/2020

[View](/is/documents/all-authorised-presentations/nexium-control-epar-all-authorised-presentations_is.pdf)

italiano (IT) (30.15 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

10/07/2020

[View](/it/documents/all-authorised-presentations/nexium-control-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (31.32 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

10/07/2020

[View](/lv/documents/all-authorised-presentations/nexium-control-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (32.69 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

10/07/2020

[View](/lt/documents/all-authorised-presentations/nexium-control-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (32.16 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

10/07/2020

[View](/hu/documents/all-authorised-presentations/nexium-control-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (32.05 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

10/07/2020

[View](/mt/documents/all-authorised-presentations/nexium-control-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (30.9 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

10/07/2020

[View](/nl/documents/all-authorised-presentations/nexium-control-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (31.29 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

10/07/2020

[View](/no/documents/all-authorised-presentations/nexium-control-epar-all-authorised-presentations_no.pdf)

polski (PL) (31.91 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

10/07/2020

[View](/pl/documents/all-authorised-presentations/nexium-control-epar-all-authorised-presentations_pl.pdf)

português (PT) (31.12 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

10/07/2020

[View](/pt/documents/all-authorised-presentations/nexium-control-epar-all-authorised-presentations_pt.pdf)

română (RO) (30.55 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

10/07/2020

[View](/ro/documents/all-authorised-presentations/nexium-control-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (28.4 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

10/07/2020

[View](/sk/documents/all-authorised-presentations/nexium-control-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (30.31 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

10/07/2020

[View](/sl/documents/all-authorised-presentations/nexium-control-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (30.14 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

10/07/2020

[View](/fi/documents/all-authorised-presentations/nexium-control-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (30.51 KB - PDF)

**First published:**

19/09/2013

**Last updated:**

10/07/2020

[View](/sv/documents/all-authorised-presentations/nexium-control-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Nexium Control Active substance esomeprazole International non-proprietary name (INN) or common name esomeprazole Therapeutic area (MeSH) Gastroesophageal Reflux Anatomical therapeutic chemical (ATC) code A02BC05

### Pharmacotherapeutic group

Proton pump inhibitors

### Therapeutic indication

Nexium Control is indicated for the short-term treatment of reflux symptoms (e.g. heartburn and acid regurgitation) in adults.

## Authorisation details

EMA product number EMEA/H/C/002618 Marketing authorisation holder

Haleon Ireland Dungarvan Limited

Knockbrack Dungarvan Co. Waterford IRELAND

Opinion adopted 27/06/2013 Marketing authorisation issued 26/08/2013 Revision 20

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Nexium Control : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (204.73 KB - PDF)

**First published:** 08/11/2013

**Last updated:** 30/01/2025

[View](/en/documents/procedural-steps-after/nexium-control-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf)

Nexium Control-H-C-PSUSA-00001269-202403 - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Reference Number: EMA/40344/2025

English (EN) (159.91 KB - PDF)

**First published:** 30/01/2025

[View](/en/documents/scientific-conclusion/nexium-control-h-c-psusa-00001269-202403-scientific-conclusions-grounds-variation-terms-marketing-authorisation_en.pdf)

Nexium Control-H-C-2618-X-0016 : EPAR - Assessment Report - Extension

Adopted

Reference Number: EMA/85635/2017

English (EN) (755.16 KB - PDF)

**First published:** 27/06/2017

**Last updated:** 27/06/2017

[View](/en/documents/variation-report/nexium-control-h-c-2618-x-0016-epar-assessment-report-extension_en.pdf)

## Initial marketing authorisation documents

Nexium Control : EPAR - Public assessment report

Adopted

Reference Number: EMA/498929/2013

English (EN) (2.63 MB - PDF)

**First published:** 19/09/2013

**Last updated:** 19/09/2013

[View](/en/documents/assessment-report/nexium-control-epar-public-assessment-report_en.pdf)

CHMP summary of positive opinion for Nexium Control

Adopted

Reference Number: EMA/328140/2013

English (EN) (62.47 KB - PDF)

**First published:** 28/06/2013

**Last updated:** 28/06/2013

[View](/en/documents/smop-initial/chmp-summary-positive-opinion-nexium-control_en.pdf)

#### More information on Nexium Control

- [EMEA-000331-PIP01-08-M01 - paediatric investigation plan](/en/medicines/human/paediatric-investigation-plans/emea-000331-pip01-08-m01)

#### Topics

- [Medicines](https://www.ema.europa.eu/en/search?f%5B0%5D=ema_search_topics%3A61)

**This page was last updated on** 30/01/2025

## Share this page

[Back to top](#main-content)